Bacteriophage endolysins can specifically bind to and efficiently lyse host bacteria, and therefore considered promising alternatives to antibiotics. Natural endolysins, however, often have limitations such as a narrow lytic spectrum or low lytic activity, which restrict their broader application in food antibacterial control. In this study, a recombinant endolysin JD007-LY01 with a stable protein structure was constructed by fusing the binding domain of the native endolysin LY01 with the lytic domain of the exogenous endolysin JD007. Experimental results showed that JD007-LY01 lysed all Staphylococcus aureus strains and exhibited a broader lytic spectrum than LY01. The recombinant enzyme displayed optimal activity at pH 6-8 and maintained high activity at temperatures between 4°C and 40°C. In artificially contaminated milk and pork models, JD007-LY01 produced moderate reductions in viable methicillin-resistant S. aureus (MRSA) counts. It also reduced biofilm-associated cell counts on polystyrene and stainless steel surfaces. Collectively, these results indicate that JD007-LY01 exhibits improved lytic activity and a broader spectrum compared with LY01, supporting the feasibility of domain recombination as a strategy to enhance certain antibacterial properties of endolysins.